Health catalyst, inc. (HCAT)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19
Cash flows from operating activities
Net loss

-17,490

-14,266

-21,416

-10,694

-13,720

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

2,877

2,368

2,316

2,216

2,312

Loss on extinguishment of debt

0

0

0

0

-1,670

Amortization of debt discount and issuance costs

285

284

281

372

144

Investment discount and premium amortization

6

172

169

191

83

Gain on sale of property and equipment

2

3

2

23

11

Stock-based compensation expense

8,741

4,816

9,974

1,398

1,656

Deferred tax benefit

-1,280

-

-

-

0

Change in fair value of contingent consideration liability

-359

-

-

-

0

Other

-2

-

-

-

0

Change in operating assets and liabilities:
Accounts receivable, net

7,284

-3,450

-3,453

6,219

557

Deferred costs

-444

-41

133

87

109

Prepaid expenses and other assets

2,244

275

978

-130

185

Operating lease right-of-use assets

-682

-707

-704

-1,016

-130

Accounts payable, accrued liabilities, and other liabilities

-4,283

-1,747

3,305

-1,262

-382

Deferred revenue

3,936

-7,524

-2,075

5,664

4,012

Operating lease liabilities

-784

-765

-742

-737

-101

Net cash used in operating activities

-16,769

-13,061

-5,482

-8,417

-5,224

Cash flows from investing activities
Purchases of property and equipment

506

741

595

374

689

Proceeds from the sale of property and equipment

6

22

2

24

14

Purchase of short-term investments

0

34,563

180,935

9,783

30,726

Proceeds from the sale and maturity of short-term investments

66,653

13,400

24,980

9,150

3,147

Purchase of intangible assets

758

188

770

575

402

Acquisition of business, net of cash acquired

15,249

-

-

-

0

Net cash provided by (used in) investing activities

50,146

-22,070

-157,318

-1,558

-28,656

Cash flows from financing activities
Proceeds from the issuance of redeemable convertible preferred stock, net of issuance costs

0

0

0

0

12,073

Proceeds from exercise of stock options

9,046

479

552

817

808

Proceeds from employee stock purchase plan

1,289

-

-

-

0

Payment of SVB line of credit and mezzanine loan

0

0

0

0

21,821

Proceeds from credit facilities, net of debt issuance costs

0

0

0

0

47,169

Payments of acquisition-related consideration

748

940

0

383

390

Payments of deferred offering costs

0

203

2,377

1,848

182

Net cash provided by financing activities

9,587

1,098

194,040

-1,414

37,657

Effect of exchange rate changes

-31

-

-

-

0

Net increase in cash and cash equivalents

42,933

-34,027

31,240

-11,389

3,777

Supplemental disclosures of non-cash investing and financing information
Redeemable convertible preferred stock accretion

0

0

18,170

98,641

64,015

Deferred offering costs included in accounts payable and accrued liabilities

427

-203

-965

102

1,066

Purchase of intangible assets included in accounts payable and accrued liabilities

132

322

0

190

1,114

Purchase of property and equipment included in accounts payable and accrued liabilities

77

54

145

-10

20

Supplemental disclosures of cash flow information related to leases
Supplemental disclosures of cash flow information related to leases
Cash paid for operating lease liabilities in operating cash flows

843

822

821

827

778

Operating lease right-of-use assets obtained in exchange for operating lease obligations

0

0

0

0

581